×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CODX – co-diagnostics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CODX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/18
09:34 am
codx
Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India [Yahoo! Finance]
Low
Report
Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India [Yahoo! Finance]
12/18
09:00 am
codx
Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India
Low
Report
Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India
12/17
09:00 am
codx
Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation
Low
Report
Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation
12/9
09:00 am
codx
Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025
Medium
Report
Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025
12/8
12:36 pm
codx
Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India
Low
Report
Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India
11/26
10:09 am
codx
Co-Diagnostics (NASDAQ:CODX) was upgraded by analysts at Maxim Group to a "hold" rating.
Medium
Report
Co-Diagnostics (NASDAQ:CODX) was upgraded by analysts at Maxim Group to a "hold" rating.
11/26
08:46 am
codx
Co-Diagnostics (NASDAQ:CODX) is now covered by analysts at Maxim Group. They set a "buy" rating and a $1.50 price target on the stock.
High
Report
Co-Diagnostics (NASDAQ:CODX) is now covered by analysts at Maxim Group. They set a "buy" rating and a $1.50 price target on the stock.
11/24
08:06 am
codx
Co-Diagnostics (NASDAQ:CODX) had its "neutral" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Co-Diagnostics (NASDAQ:CODX) had its "neutral" rating reaffirmed by analysts at HC Wainwright.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/19
04:31 pm
codx
Form 424B5 Co-Diagnostics, Inc.
Low
Report
Form 424B5 Co-Diagnostics, Inc.
12/5
04:31 pm
codx
Form 8-K Co-Diagnostics, Inc. For: Dec 05
Medium
Report
Form 8-K Co-Diagnostics, Inc. For: Dec 05
11/24
05:47 pm
codx
Form 4 Co-Diagnostics, Inc. For: Nov 23 Filed by: Murphy Edward L.
Low
Report
Form 4 Co-Diagnostics, Inc. For: Nov 23 Filed by: Murphy Edward L.
11/24
05:32 pm
codx
Form 4 Co-Diagnostics, Inc. For: Nov 23 Filed by: Brown Brian Lee
Low
Report
Form 4 Co-Diagnostics, Inc. For: Nov 23 Filed by: Brown Brian Lee
11/24
05:31 pm
codx
Form 4 Co-Diagnostics, Inc. For: Nov 23 Filed by: SERBIN RICHARD S
Low
Report
Form 4 Co-Diagnostics, Inc. For: Nov 23 Filed by: SERBIN RICHARD S
11/24
05:31 pm
codx
Form 4 Co-Diagnostics, Inc. For: Nov 23 Filed by: Abbott Richard David
Low
Report
Form 4 Co-Diagnostics, Inc. For: Nov 23 Filed by: Abbott Richard David
11/24
05:31 pm
codx
Form 4 Co-Diagnostics, Inc. For: Nov 23 Filed by: Egan Dwight H
Low
Report
Form 4 Co-Diagnostics, Inc. For: Nov 23 Filed by: Egan Dwight H
11/24
05:29 pm
codx
Form 4 Co-Diagnostics, Inc. For: Nov 23 Filed by: Durenard Eugene
Low
Report
Form 4 Co-Diagnostics, Inc. For: Nov 23 Filed by: Durenard Eugene
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/10
Co-Diagnostics down 39% on proliferation of COVID-19 competitors [Seeking Alpha]
89.0%
1/23 Co-Diagnostics, Inc. Designs Test for New Coronavirus Using CoPrimer™ Platform 79.6%
1/27 Vaccine, diagnostics stocks rise again on spreading coronavirus [MarketWatch] 38.1%
2/28 Form 424B5 Co-Diagnostics, Inc. 35.0%
4/16 Co-Diagnostics, Inc. COVID-19 Test Technology Validated for Use on Saliva Samples 30.6%
2/10 Co-Diagnostics, Inc. Announces Sales of New Coronavirus Test 28.2%
7/18 Co-Diagnostics Inc CoPrimers Provide High-Performance Detection of Cancer Mutations in Liquid Biopsy Samples 26.4%
2/6 Co-Diagnostics, Inc. Announces Launch of Test for New Coronavirus 24.2%
2/24 Co-Diagnostics, Inc. Receives CE Mark for Novel Coronavirus Test 20.2%
1/31 Coronavirus update: 213 dead, more countries recommending against China travel [MarketWatch] 19.4%
1/23 Co-Diagnostics, Inc. Designs Test for New Coronavirus Using CoPrimer™ Platform 79.6%
1/27 Vaccine, diagnostics stocks rise again on spreading coronavirus [MarketWatch] 38.1%
2/28 Form 424B5 Co-Diagnostics, Inc. 35.0%
4/16 Co-Diagnostics, Inc. COVID-19 Test Technology Validated for Use on Saliva Samples 30.6%
2/10 Co-Diagnostics, Inc. Announces Sales of New Coronavirus Test 28.2%
7/18 Co-Diagnostics Inc CoPrimers Provide High-Performance Detection of Cancer Mutations in Liquid Biopsy Samples 26.4%
2/6 Co-Diagnostics, Inc. Announces Launch of Test for New Coronavirus 24.2%
2/24 Co-Diagnostics, Inc. Receives CE Mark for Novel Coronavirus Test 20.2%
1/31 Coronavirus update: 213 dead, more countries recommending against China travel [MarketWatch] 19.4%
TOP News Decliners
2/28
Why Acquisition & Coordination of First Responders Data On COVID-19 Becoming Critically Essential
-34.3%
3/9 Co-Diagnostics Inc (NASDAQ: CODX) had its price target raised by analysts at HC Wainwright from $4.00 to $20.00. They now have a "buy" rating on the stock. -28.8%
3/12 Global Response to the COVID-19 Outbreak Intensifies -25.6%
1/27 Form 424B5 Co-Diagnostics, Inc. -23.6%
2/10 Co-Diagnostics up 36% on coronavirus test sales [Seeking Alpha] -19.7%
1/31 Coronavirus update: Trump declares coronavirus a public health emergency, U.S. citizens returning from Hubei Province to be quarantined [MarketWatch] -18.5%
3/2 Co-Diagnostics CEO on FDA's coronavirus policy changes [Yahoo! Finance News] -18.4%
3/3 Faulty COVID-19 Test Kits Tilt Scales in Coronavirus's Favor [The Motley Fool] -13.7%
3/17 Co-Diagnostics says new FDA policy to help expand use of COVID-19 test [Reuters (UK)] -13.5%
2/18 Co-Diagnostics (NASDAQ:CODX) Helping to Mitigate Global Economic Risk -12.8%
3/9 Co-Diagnostics Inc (NASDAQ: CODX) had its price target raised by analysts at HC Wainwright from $4.00 to $20.00. They now have a "buy" rating on the stock. -28.8%
3/12 Global Response to the COVID-19 Outbreak Intensifies -25.6%
1/27 Form 424B5 Co-Diagnostics, Inc. -23.6%
2/10 Co-Diagnostics up 36% on coronavirus test sales [Seeking Alpha] -19.7%
1/31 Coronavirus update: Trump declares coronavirus a public health emergency, U.S. citizens returning from Hubei Province to be quarantined [MarketWatch] -18.5%
3/2 Co-Diagnostics CEO on FDA's coronavirus policy changes [Yahoo! Finance News] -18.4%
3/3 Faulty COVID-19 Test Kits Tilt Scales in Coronavirus's Favor [The Motley Fool] -13.7%
3/17 Co-Diagnostics says new FDA policy to help expand use of COVID-19 test [Reuters (UK)] -13.5%
2/18 Co-Diagnostics (NASDAQ:CODX) Helping to Mitigate Global Economic Risk -12.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: